Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2791 of 6351
-
Balance training with biofeedback: a new hope for stroke fall prevention?
Symptom relief Recruiting nowThis randomized controlled trial aims to evaluate the effects of task-specific training with and without biofeedback compared to conventional physical therapy on balance and fall risk in chronic ischemic stroke patients in Lahore, Pakistan. Sixty-six participants will be randomly…
Sponsor: Syed Ali Behram Subazwari • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New hope for MS patients: can a drug switch stop symptom comebacks?
Symptom relief Recruiting nowThe proposed study is a pilot study of ublituximab involving people with multiple sclerosis (MS) who are experiencing a "wearing off" phenomenon (return or worsening of MS-related symptoms) while being treated with ocrelizumab, and exploring whether switching to ublituzimab can r…
Phase 4 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Heart MRI registry aims to unlock myocarditis risk secrets
Knowledge-focused Not yet recruitingAcute myocarditis is a major cause of death in young adults and carries substantial morbidity, including a significant risk of progression to dilated cardiomyopathy. Current diagnostic and therapeutic strategies remain poorly defined, making risk stratification crucial to enable …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
New nasal COVID vaccine could replace needles
Vaccine OngoingThis is a Phase 1a, single-country, single-centre, single-blinded, COV2 vaccine formulation randomized trial designed to investigate and compare the safety and immunogenicity of two COV2 vaccine formulations. COV2 is a nasal, investigational vaccine against COVID-19, based on a s…
Phase 1 • Sponsor: Rokote Laboratories Finland Oy • Aim: Vaccine
Last updated Jul 24, 2026 00:00 UTC
-
Stroke patients try intensive Tech-Powered rehab in swiss study
Disease control Recruiting nowHigh-dose, high-intensity (HDHI) neurorehabilitation has shown promise for improving functional outcomes after acquired brain injury (ABI), yet its feasibility and impact across different stages of care and real-world clinical settings remain insufficiently understood. The Swiss…
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Eye training trial aims to boost vision in glaucoma patients
Symptom relief Recruiting nowThis randomized controlled clinical trial evaluates the efficacy of visual biofeedback training on visual function and quality of life in individuals with glaucoma. Glaucoma is a progressive optic neuropathy that can lead to irreversible vision loss, including impaired fixation s…
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New drug combo could offer better gout control for patients not helped by standard pills
Disease control Recruiting nowSHR4640 tablets is a highly selective and potent URAT1 inhibitors. The study is being conducted to evaluate the efficacy, and safety of SHR4640 tablet combined with 40 mg/d febuxostat tablet in reducing uric acid in subjects with primary gout and hyperuricemia The primary purpose…
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Virtual reality workouts show promise for chronic back pain relief
Symptom relief CompletedOne of the most prevalent causes of pain on a global scale is chronic musculoskeletal pain. Low back pain is a prevalent manifestation of chronic musculoskeletal pain. There are a wide vary of no pharmacologic treatment for chronic pain. From a physiotherapy perspective, the chr…
Sponsor: Universidad de Granada • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can village volunteers and a phone app help smokers quit?
Disease control CompletedBrief Summary What is the purpose of this research? The goal of this study is to test a new method to help informal workers in Thailand quit smoking. The investigators seek to determine if a community-based system using digital tools (such as the Line app) is more effective than …
Sponsor: Mahidol University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a sensor device boost brain and body recovery after hip fracture?
Symptom relief Recruiting nowThe aim of this study is to evaluate whether integrating a technology-based rehabilitation approach with conventional therapies in the rehabilitation of patients with proximal femoral fracture may be advantageous compared with conventional therapy alone. Specifically, the objecti…
Sponsor: C.O.T. Cure Ortopediche Traumatologiche S.p.A. • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Pickleball power: new study tests sport as brain booster for teens with disabilities
Symptom relief OngoingThis study aims to investigate the effects of a 12-week pickleball training program on cognitive and motor outcomes in adolescents with mild intellectual disability. Pickleball is a low-impact racket sport that combines elements of tennis, badminton, and table tennis, and is cons…
Sponsor: Elif Top • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New pain cocktail aims to cut opioid use after brain surgery
Symptom relief Not yet recruitingSupratentorial craniotomy is one of the most common neurosurgical procedures, with severe perioperative pain. Inadequate perioperative pain relief has been associated with increased blood pressure and intracranial pressure, favoring bleeding and cerebral cerebral hypoperfusion. T…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Psoriasis patients switch biologics in new Real-World study
Disease control Stopped earlyThe purpose of this study is to assess the effectiveness and safety of guselkumab following a switch from ustekinumab or an ustekinumab biosimilar in participants with moderate to severe psoriasis, a chronic inflammatory skin disease characterized by erythematous, scaly plaques t…
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Grape extract may shield hearts of breast cancer patients during chemo
Disease control Not yet recruitingThis pilot randomized clinical study aims to evaluate the cardioprotective effects of a grape polyphenol concentrate in patients receiving anthracycline- and/or trastuzumab-based chemotherapy. Adult patients at high or very high risk of chemotherapy-induced cardiotoxicity will be…
Sponsor: Nazarbayev University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New nasal spray aims to stop asthma Flare-Ups triggered by common cold
Disease control Recruiting nowNested Phase 1-2 Trial of RIG-101 in Healthy and Asthmatic Participants Assessing Safety, Tolerability and Viral Challenge Efficacy
Phase 1/2 • Sponsor: RIGImmune Inc. • Aim: Disease control
Last updated Sep 09, 2026 22:00 UTC
-
Robot ankle brace could make walking easier for stroke survivors
Symptom relief CompletedThis work will focus on new algorithms for robotic ankle exoskeletons and testing these in human subject tests. Individuals who have previously had a stroke will walk while wearing a robotic exoskeleton on a specialized treadmill as well as during other movement tasks (e.g., over…
Sponsor: Georgia Institute of Technology • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
New drug could replace opioids for knee surgery pain
Symptom relief By invitation onlyThe purpose this study is determine whether postoperative oral dosage of suzetrigine is effective at controlling postoperative pain and reducing analgesic requirements following primary total knee arthroplasty (TKA) versus a control group of TKA patients receiving postoperative O…
Phase 4 • Sponsor: University of Louisville • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can brain chemistry predict who benefits from stimulation?
Knowledge-focused Recruiting nowThe project aims to explore changes in brain chemistry in individuals who have recently experienced psychosis. Recent research suggests that chemicals in the brain, specifically one called glutamate, may behave differently in people who have experienced psychosis compared to thos…
Sponsor: University of Nottingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Kids' CF drug levels under the microscope: new study aims to personalize dosing
Knowledge-focused Recruiting nowCystic fibrosis is a rare, progressive genetic disease caused by a mutation in the CFTR (cystic fibrosis transmembrane conductance regulator) gene. Respiratory and nutritional effects are crucial to patients' prognosis. Since the early years of 2010, etiological treatment has bee…
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Can magnetic pulses calm the brain in PTSD and depression?
Knowledge-focused Not yet recruitingThis study aims to investigate the immediate neurophysiological and autonomic effects of two noninvasive brain stimulation protocols-prolonged intermittent theta-burst stimulation (prolonged iTBS) and high-frequency repetitive transcranial magnetic stimulation (HF-rTMS)-in patien…
Sponsor: Tri-Service General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC